No higher resolution available.
This file is from a shared repository and may be used by other projects.
The description on its file description page there is shown below.
License
Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)
Summary
Author:Takano S, Ishikawa E, Nakai K, Matsuda M, Masumoto T, Yamamoto T, Matsumura A,Department of Neurosurgery, Faculty of Medicine, University of Tsukuba(Openi/National library of Medicine) Source:https://openi.nlm.nih.gov/detailedresult?img=PMC4161529_ott-7-1551Fig10&query=&req=4 Description:f10-ott-7-1551: Clinical case: 44-year-old female patient with right frontal recurrent glioblastoma.Notes: Serial MRI during bevacizumab monotherapy (10 mg/kg every 2 weeks for 12 weeks). (A) T1Gd-enhanced MRI on pretreatment, 8 weeks after treatment, and 20 weeks after treatment. Gelatin zymogram for MMP activities in urine at sequential periods. (B) MMP activity in urine appeared only as MMP2 at pretreatment, disappeared during 1 week, 2 weeks, 6 weeks, and 12 weeks, and appeared as both MMP2 and MMP9 at 20 weeks.Abbreviations: MMP, matrix metalloproteinase; TIMP2, tissue inhibitor of metalloproteinase 2; MRI, magnetic resonance imaging; T1Gd, Gd-enhanced T1 image.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment |
|---|
| current | 20:00, 21 January 2022 |  | 512 × 350 (129 KB) | Ozzie10aaaa | Author:Takano S, Ishikawa E, Nakai K, Matsuda M, Masumoto T, Yamamoto T, Matsumura A,Department of Neurosurgery, Faculty of Medicine, University of Tsukuba(Openi/National library of Medicine) Source:https://openi.nlm.nih.gov/detailedresult?img=PMC4161529_ott-7-1551Fig10&query=&req=4 Description:f10-ott-7-1551: Clinical case: 44-year-old female patient with right frontal recurrent glioblastoma.Notes: Serial MRI during bevacizumab monotherapy (10 mg/kg every 2 weeks for 12 weeks). (A) T1Gd-enha... |
File usage
The following page uses this file:
